Timothy Schmid - 14 Feb 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, MedTech
Signature
/s/ Laura H. McFalls, as attorney-in-fact for Timothy Schmid
Issuer symbol
JNJ
Transactions as of
14 Feb 2025
Net transactions value
-$159,061
Form type
4
Filing time
18 Feb 2025, 21:46:21 UTC
Previous filing
18 Feb 2025
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +2,806 +19% $0.000000 17,904 14 Feb 2025 Direct F1
transaction JNJ Common Stock Tax liability $159,061 -1,015 -5.7% $156.71 16,889 14 Feb 2025 Direct F2
holding JNJ Common Stock 722 14 Feb 2025 By 401k F3
holding JNJ Common Stock 46 14 Feb 2025 By ESOP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Performance Share Units Options Exercise $0 -2,806 -100% $0.000000 0 14 Feb 2025 Common Stock 2,806 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.
F2 Shares withheld for payment of taxes upon vesting of PSUs.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).
F4 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).